Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer.
about
Parenteral anticoagulation in ambulatory patients with cancerOral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulationPrimary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapyOral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulationPrimary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapyOral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulationOral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulationThe cancer stem cell: evidence for its origin as an injured autoreactive T cellVenous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer AnticoagulantsPrimary prevention and treatment of venous thromboembolic events in patients with gastrointestinal cancers - ReviewPlatelets, coagulation and fibrinolysis in breast cancer progressionAnticoagulants in cancerThromboprophylaxis guidelines in cancer with a primary focus on ambulatory patients receiving chemotherapy: a review from the Southern Network on Adverse Reactions (SONAR)Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysisThe hypercoagulable state of malignancy: pathogenesis and current debateOpportunity cost of funding drugs for rare diseases: the cost-effectiveness of eculizumab in paroxysmal nocturnal hemoglobinuriaThe effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trialsVenous thromboembolism in malignant gliomasWhen are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data.Safety of low-dose low-molecular-weight-heparins in thrombocytopenic stem cell transplantation patients: a case series and review of the literature.Low-molecular-weight heparin versus placebo for the prevention of venous thromboembolism in metastatic breast cancer or stage III/IV lung cancer.Treating venous thromboembolism in patients with cancer.Cancer and Venous Thromboembolic Disease: A Review.Clinical trials on antiphospholipid syndrome: what is being done and what is needed?Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action.Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin.Cancer and venous thromboembolic disease: from molecular mechanisms to clinical management.Predictors of venous thromboembolism in patients with advanced common solid cancersThe risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review.Adverse Interaction between Capecitabine and Warfarin Resulting in Altered Coagulation Parameters: A Review of the Literature Starting from a Case Report.Oral anticoagulation and risk of death: a medical record linkage study.Venous thrombosis and anticoagulant therapy.Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.Venous thromboembolism in the outpatient settingArterial and venous thrombosis in cancer patientsWarfarin for refractory chronic cluster headache: a randomized pilot study.Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.Agreement of four competing guidelines on prevention of venous thromboembolism and comparison with observed physician practices: a cross-sectional study of 1,032 medical inpatientsPharmacological thromboembolic prophylaxis in a medical ward: room for improvement.Long-term, low-intensity warfarin after idiopathic venous thromboembolism.
P2860
Q22252972-7725238A-FFD5-4A08-8244-969D109EB323Q24194116-31E7C3F9-C80F-45A9-9B8A-A9902E3E1E1AQ24194257-47D1DCBE-2CE0-4401-8D5A-306359B609BDQ24194926-9D8935BA-0555-401A-B780-DF6A345853D1Q24203644-2FD20541-504F-40C8-A318-4B40F7B2C8B1Q24235785-57C2F9E6-AC7E-4840-A177-46C527C78A80Q24236595-9F3686BD-A71F-4532-B205-E70612B6DF25Q25256839-42DEBD0D-C438-48F5-9FD7-BB5A5347DE94Q26741697-2871149B-CE96-43E3-9891-CA8E01316FBAQ26753853-0B49926F-B659-440B-B6F0-F908A9F4B073Q26823716-52E9AA8C-18AB-4429-AA25-3AF4F88BFECAQ26825228-72B1DAB1-05F2-41BB-A2F8-55E93EEA4C43Q26995284-448722D4-AB8D-4E5B-A4B2-FECD056C79B6Q27005043-767DB5AC-9BB9-4D85-AF15-A7D96F4F39C0Q28212265-005BCF11-B719-45CA-8068-DF32721C9FC1Q28243221-4A3AECAC-D208-4589-9842-3CC884C9C8CEQ28296482-1902F664-81EB-484D-9A87-C838394DD803Q30436810-D8EC52DA-E262-4459-90FA-2EE11A1513ECQ31024426-EDE27513-A765-4947-BC85-29128EB5143DQ33365781-BB872353-2C46-4389-A375-B99BE77A57BCQ33399333-2B1E7F55-F52C-484A-9FD1-54975E5EC81CQ33400564-C5B82F90-9CAB-43A4-ADBA-C302F20AC77CQ33439089-9A839A19-B663-47F4-AC4C-A363F3A60ADDQ33490045-C83EA6EF-84A9-4897-95AE-90D98E519AECQ33561213-54D637A2-F84D-4624-AE1C-AFD13C7FAEEAQ33671179-692ADBF3-5FDD-47DF-A9C3-1697E62D0F54Q33763866-7EEC2B22-22B1-481A-9000-94AFE31CD977Q33810510-765E5DCE-0D4C-48F9-8320-9274066F4D32Q33994652-DF4D91E7-2DF9-4C78-92F4-AA8675782F3DQ34019240-2E750FFB-F795-4737-82A6-120BB9D815E6Q34210279-B97DFB25-F2CE-4992-B179-C7EA0E7C152CQ34351113-D9E11D69-D1AC-4D2A-86CE-2676C276BAC6Q34546366-AE38B49C-6F76-417A-A8DA-AA28334D3BA7Q34581299-ACC1A8E8-B41A-4B2B-8307-316D6BE4BBE5Q34635182-46714C8B-63D7-422D-A1D6-712DAF423F1AQ34660438-61FD4E5D-D3CE-4630-839B-8C57D6A12206Q34688195-12F7356A-01D1-4874-BA04-9F5AE6E70783Q34733377-1052392C-3EA9-40FB-AB3E-FCE40C4ECDA9Q34743419-EB88F80B-A9C6-4767-8324-E0A8C3B53E15Q34963687-5D99E10F-CBE9-407C-A2DC-3DFC60F9BD84
P2860
Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Double-blind randomised trial ...... ism in stage IV breast cancer.
@en
Double-blind randomised trial ...... ism in stage IV breast cancer.
@nl
type
label
Double-blind randomised trial ...... ism in stage IV breast cancer.
@en
Double-blind randomised trial ...... ism in stage IV breast cancer.
@nl
prefLabel
Double-blind randomised trial ...... ism in stage IV breast cancer.
@en
Double-blind randomised trial ...... ism in stage IV breast cancer.
@nl
P2093
P1433
P1476
Double-blind randomised trial ...... ism in stage IV breast cancer.
@en
P2093
K I Pritchard
V Bramwell
P304
P356
10.1016/S0140-6736(94)90008-6
P407
P50
P577
1994-04-01T00:00:00Z